Medical Marijuana, Inc. (OTCMKTS:MJNA) Receives Publicity From Multiple Sources


One cannabis stock that we regularly track here at Street Register is Medical Marijuana, Inc. (OTCMKTS:MJNA). Our penchant for the cannabis trade is no secret, and MJNA happens to be America’s first publicly traded cannabis stock.


It has been some time since we last checked in with MJNA, and recently the company has gotten significant publicity boosts from a couple of different sources.


This week Medical Marijuana, Inc. (OTCMKTS:MJNA) has newly announced that its flagship product Real Scientific Hemp Oil™ (RSHO™) will be featured in an upcoming segment on the Emmy® Award-winning daytime talk show, CBS’ The Doctors on Tuesday, March 27, 2018.


The segment, which highlights the many health and wellness benefits of cannabidiol (CBD), features medical cannabis expert and doctor Bonni Goldstein M.D and hosts ER physician Dr. Travis Stork, plastic surgeon and reconstructive surgery expert Dr. Andrew Ordon and board-certified OB/GYN Dr. Nita Landry.


The product featured, Real Scientific Hemp Oil™, is a pure non-GMO hemp oil, unmodified and sourced straight from the hemp plant. RSHO™ is extracted from hemp cultivated free of chemical fertilizers, pesticides or herbicides in the foothills of Northern Europe.


“Real Scientific Hemp Oil is the product that put our Company on the map and positioned us as a leader in the CBD hemp oil industry,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope that this national TV exposure will help even more people across the nation understand why they should be taking a daily supplement of CBD.”


Medical Marijuana, Inc. sells RSHO™ through its distribution subsidiary, HempMeds®. HempMeds® was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 and was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay. (Source: PR Newswire)


In another recent development, MJNA’s Phyto Animal Health subsidiary garnered coverage in a top veterinary trade publication, American Veterinarian. A March 13, 2018, article on the American Veterinarian website entitled “Phyto Animal Health’s Line of CBD Pet Products,” features interviews with executive members of the  Phyto Animal Health Veterinary Advisory Board, Liz Hughston, MEd., RVT, CVT, VTS (SAIM, ECC), and Stephen F. Cital, RVT, SRA, RLAT, VTS-Lab Animal.

The article, which includes a video interview, outlines how Phyto Animal Health products are made of the highest quality cannabidiol (CBD) hemp oil products available on the market because of the Company’s laboratory testing procedures – which ensure that the products are pure and have a wide variety of terpenoids and flavonoids. These qualities are important because they make the products palatable and provide a full-spectrum of benefits.


“We want all of our subsidiaries to be known as leaders in their respective product markets and are pleased to see these veterinary experts endorsing Phyto Animal Health in this nationally recognized publication,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. (Source: PR Newswire)


Meanwhile, after what looked like what might be a big start to 2018 by MJNA on the chart, did not pan out in such a way. It has seen largely consolidation in the past few months, but we will be interested to watch for a bottom as we approach April, which is one of the biggest months of the year for the cannabis industry. We’ll stay up on any further developments with MJNA and pass them along to you! Stay locked on and be sure you’re signed up for our 100% free smallcap newsletter. It’s as easy as that! Simply submit your primary active email address in the box below. Subscribe now!


   Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in MJNA stock, short or long.